How the body processes drugs in people with cirrhosis
Part of Digestive system clinical trials.
This study looks at how the body processes certain common medications in people with cirrhosis. The goal is to better predict how these drugs work in patients with liver disease, which could help tailor treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of cirrhosis (a condition where the liver is scarred).
- Your liver disease must not be too severe: a MELD score of 30 or lower (a standard measure of liver function).
- Your kidneys must be functioning well (estimated creatinine clearance of at least 30).
- You must not be taking certain medications or have allergies that would interfere with the study drugs.
- You must be able to give informed consent — that is, understand the study and agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
This study looks at new blood markers to better predict recovery in patients hospitalized for complications of cirrhosis (like fluid buildup, confusion, or bleeding). You may qualify if you were recently hospitalized for these issues and are expected to go home soon.
This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
This study checks how well your liver breaks down certain medications based on your genes. It aims to find new ways to predict your natural liver function, which could help doctors prescribe the right drug dose for you.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.